Table Of Content

Author Index Arnason B.G. W. 125 Hoogenboom H.R. 211 PetteM. 97 Huleatt J. W. 463 Piercy C. 51 BachN. 199 Posner J.B. 85 Blumberg R.S. 449 Jassoy C. 341 Puddington L. 463 Bolhuis R.L.H. 211 Jensen M.A. 125 Bolognesi D. P. 355 JungS. 97 OuZex.. 125 Brad| M. 35 Brandtzaeg P. 535 555 Kelsall B. L. 407 409 Reder A. T. 125 Brocke S. 51 Kiessling R. 227 Richmann D. D. 267 Kiyono H. 477 RiethmiillerG. 243 Chen C.-H. 355 Kono K. 227 Romero P. 185 Chong H. 149 KoupR. A. 323 Rugtveit J. Christ A.D. 449 Kurth R. 391 Cohen O. J. 305 Kweon M.-N. 477 Said G. 75 Czinn S.J. 495 Schindler D.G. 199 Lacey S.F. 355 Schneider T. 515 Dalmau J. 85 Lam G.K. 305 Scott H. 535 DavisI.C. 421 Lefrangois L. 463 Selmaj K. 57 Dayal A. 125 Lundin K. E. A. 535 Sollid L.M. 535 Lustgarten J. 199 Steinman L. 51 Engelhard V.H. 171 Strober W. 407 409 Eshhar Z. 199 MartinR. 1 McFarland H. 1 Thorsby E. 535 Fauci A.S. 253 257 305 McGhee J.R. 477 Toyka K. V. 97 Fitzer-Attas C.J. 199 Meyaard L. 285 Fujihashi K. 477 Miedema F. 285 Ullrich R. 515 Fuller B. 463 Molberg @. 535 Montefiori D.C. 371 van Ginkel F W. 477 Geng K. 125 VanCott J.L. 477 Giegerich G. 97 Nedrud J.G. 495 VileR.G. 149 GratamaJ.W. 211 Nilsen E. 535 GraziosiC. 257 Norley S. 391 Waks T. 199 Greenberg M.L. 355 Walker B.D. 341 Gross G. 199 Olson S. 463 Wasserman K. 227 Gruber R. 243 Owen R.L. 421 Weinhold K. J. 355 Willison H. 97 Haraldsen G. 555 Pachner A. R. 25 Hartung H.-P. 97 Pantaleo G. 253 257 305 Yamamoto M. 477 Havlir D. V. 267 Paxton W.A. 323 Holz E. 243 Petersson M. 227 Zeitz M. 515 Subject Index Adhesion molecules 57 glycolipid antibodies 97 AIDS 25, 341, 371, 391 glycosylation 371 alpha/bTe ctelal s 477 Guillain-Barré syndrome 97 antibodies 371, 555 antigen presentation 409 H,0, 227 antiretroviral therapy 305 helicobacter pylori 495 appendix 421 -,immunopathology 495 astrocytes 35 -, vaccines 495 autoantigens 35 human immunodeficiency virus (HIV) 25, autoimmunity 51, 535 295,291,911; 391, 421 transmission 323 B lymphocytes 371,555 antiretroviral therapy 305 B. burgdorferi 25 CD8-cell factor 345 blood brain barrier 35,57 cellular immunity 355 cytotoxic Tlymphocytes 341 Cancer 185, 211, 227 dynamics 267 cancer therapy, monoclonal antibodies , immunology 285 243 immunopathogenesis 253 CC CKR-S5 B-chemokine receptors 323 lymphoid tissue 305 CD8 cells 355 natural host 391 CD8-cell factor, HIV 345 pathogenesis 267, 285, 391 celiac disease 407, 535 primary infection 257 cellular immunity, HIV 355 resistance to 323 central nervous system, infection 25 role of complement 371 chemokines 355 -, virus escape 257, 260 chimeric receptors 199, 211 —, virus suppression 355 class | MHC associated peptides 171 HIV-1 355 complement 371 complement activation 555 IgA 421,555 CTLepitopes 341 IgG subclasses 555 cytokines 57, 227,555 immune neuropathies 97 immune response 371] Delayed-type hypersensitivity 125 immune suppression 227 demyelinating diseases 1 immunity 97 demyelinating disease, superantigens -, mucosal 449 51 immunopathology demyelination 97 —, mucosal, Vol. 18, no. 4 dendritic cells 371, 407, 409 immunotherapy 149, 199 -, MS 1 Encephalitis 25 infection, CNS 25 epithelial cells 407, 477 infectious disease 211 epithelium 449 inflammation 57 experimental allergic encephalitis inflammatory bowel disease 407, 421,555 (EAE) 1 interferon-B 125 experimental allergic neuritis (EAN) 97 intestinal immunity 463 experimental encephalomyelitis 51 intestinal mucosa 449 intestine 409, 421, 515 Gamma/delta T cells 477 intraepithelial lymphocytes (IEL) 463 gangliosides 97 -, development 463 gastritis 407, 495 — -, extrathymic 463 gastrointestinal tract isolated neuropathy, NA 78 gene therapy 149, 211 gluten 535 Lamina propria 409 gluten-sensitive enteropathy 535 Lyme disease 25 Subject Index lymph nodes 371 Reovirus lymphocytes 407 retinoic acid 125 lymphoid tissue, HIV 305 rheumatoid arthritis —, necrotizing arteritis 75 Meells 421 macrophages 555 Salmonella 421 MAGE gene _ 185 Schwann cells 97 Melan-A/MART-1 185 secretory IgA 477 melanoma 185 secretory immunity meningitis 25 Shigella 421 MHC molecules, class! 171 signal transducing zeta chains 227 microbial pathogenesis 421 simian immunodeficiency virus (SIV) 391 microglia 35 superantigens 51 migration, Tlymphocytes 35 monoclonal antibodies 242 T cell receptors (TCR) 185 -, cancer therapy 243 T cells mucosa 407 -, targeting 211 mucosal immunity 421,515 —, tumor-specific 199 multiple sclerosis (MS) 1,51, 125 -, migration 35 -, immunotherapy 1 T lymphocytes, cytolytic (CTL) 171, 185 myelin 97 T lymphocytes, cytotoxic 244, 341, 463 Thl, Th2 cytokines 477 Necrotizing arteritis (NA) 75 thymus 463 —, isolated neuropathy 78 tonsillitis —, rheumatoid arthritis 75 tropism 371 nerve 97 tumor antigen 171, 185 nervous system 35 tumor-associated antigen 244 neurologic paraneoplastic syndromes tumor-specific T cells 199 85 tyrosinase 185 Peyer’s patches 409, 421 Vaccination 244 phagocytosis 371 vascular endothelium 555 poliovirus 421 vasculitis, diagnosis 81 polyarteritis nodosa (PAN) 75 virus suppression, HIV 355 primary vasculitis 76 virus 25 progressive multifocal leukoencephalopathy 25 Yersinia 421